Volume 13, Number 12—December 2007
Research
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005
Eili Klein*, David L. Smith†, and Ramanan Laxminarayan*
Table 2
Hospitalizations and rates of infections with Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) by region and year, United States*
| Region | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 |
|---|---|---|---|---|---|---|---|
| Northeast | 8.42 (3.58) | 8.61 (3.9) | 10.01 (4.9) | 10.62 (5.22) | 11.25 (5.65) | 11.07 (5.84) | 11.59 (6.12) |
| Midwest | 8.53 (3.84) | 9.59 (4.53) | 9.8 (4.84) | 9.33 (4.8) | 9.65 (5.04) | 11.29 (6.54) | 12.47 (7.23) |
| South | 9.71 (4.63) | 9.44 (4.68) | 10.14 (5.33) | 11.17 (6.15) | 12.5 (7.25) | 13.46 (8.21) | 14.77 (9.31) |
| West | 9.75 (3.15) | 8.33 (3.14) | 10.85 (4.61) | 11.05 (4.98) | 11.57 (5.87) | 13.75 (7.39) | 15.84 (8.55) |
*Rates are no. hospitalizations with S. aureus MRSA–related discharge diagnoses/1,000 discharges. Values in parentheses are rates for MRSA.
Page created: July 06, 2010
Page updated: July 06, 2010
Page reviewed: July 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.